- Home
- IBRX vs LLYVA Comparison
IBRX vs LLYVA Comparison
Compare IBRX & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBRX | LLYVA |
|---|---|---|
| Founded | 2014 | 1991 |
| Country | United States | United States |
| Employees | N/A | 54700 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 8.9B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | IBRX | LLYVA |
|---|---|---|
| Price | $7.94 | $97.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $12.57 | N/A |
| AVG Volume (30 Days) | ★ 10.9M | 99.8K |
| Earning Date | 05-08-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $113,288,000.00 | N/A |
| Revenue This Year | $88.59 | N/A |
| Revenue Next Year | $131.15 | $5.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 668.31 | N/A |
| 52 Week Low | $1.95 | $70.66 |
| 52 Week High | $12.43 | $99.82 |
Technical Indicators
Market Signals| Indicator | IBRX | LLYVA |
|---|---|---|
| Relative Strength Index (RSI) | 52.20 | 57.26 |
| Support Level | $7.77 | $77.60 |
| Resistance Level | $8.51 | $98.71 |
| Average True Range (ATR) | 0.53 | 2.71 |
| MACD | 0.04 | 0.48 |
| Stochastic Oscillator | 62.50 | 73.13 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
About LLYVA Liberty Media Corporation Series A Liberty Live
Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.